ORCHARD THERAPEUTICS PLC's ticker is ORTX and the CUSIP is 68570P101. A total of 82 filers reported holding ORCHARD THERAPEUTICS PLC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $411,000 | – | 29,925 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CHI Advisors LLC | 2,962,267 | $22,306,000 | 52.57% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 8,862,247 | $66,733,000 | 2.12% |
| RA Capital Management | 10,364,658 | $57,048,000 | 1.80% |
| Vivo Capital, LLC | 1,627,225 | $12,253,000 | 1.11% |
| Casdin Capital, LLC | 975,000 | $7,342,000 | 0.78% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 1,440,744 | $10,849,000 | 0.36% |
| Ghost Tree Capital, LLC | 178,109 | $1,341,000 | 0.36% |
| Woodline Partners LP | 591,250 | $4,452,000 | 0.32% |
| Bleichroeder LP | 125,200 | $943,000 | 0.25% |
| ArrowMark Colorado Holdings LLC | 1,488,314 | $11,207,000 | 0.15% |